Search results
Results From The WOW.Com Content Network
By the mid-1990s, Alcon’s 150-acre campus in south Fort Worth was home to nine buildings and 2,500 employees, including hundreds of research scientists, manufacturing workers and managers.
Alcon offices in Johns Creek, Georgia. Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
The company has been ranked in the top 3 in 12 global markets, the top 5 in 16 global markets, and in the top 10 in 33 global markets. Actavis also develops and out-licenses generic pharmaceutical products outside the US through its Medis third-party business, the world's largest generic pharmaceutical out-licensing business.
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
The company traces its roots back to 1948 and pharmacist Gavin S. Herbert, who in 1950 established Allergan Pharmaceuticals, Inc. Allergan focused on the discovery and development of novel formulations for specialty markets, as well as intimate collaboration with physicians and the scientific community. 1953 saw Allergan producing eye drops and formulating new products such as the first ...
Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a 250,000-square-foot expansion. Alcon Laboratories is considering a major $100M expansion of ...
In 1984, he founded the drug distribution firm Best Generics Inc. [1] and sold it to Florida's Ivax Corporation in 1988 for $10 million although he stayed on as President until 1990. In 1992, he founded Andrx Pharmaceuticals Inc., which he led as CEO to its inclusion in the Nasdaq100 in 1999.
August 8, 2024 at 10:55 AM. By Mariam Sunny. (Reuters) -The U.S. Food and Drug Administration has approved Citius Pharmaceuticals' therapy for patients with a form of blood cancer who have ...